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The need for an effective method of treatment of the superficial and systemic
mycoses is, without a doubt, an outstanding problem in medical mycology today.
The remarkable success achieved in treatment of bacterial infections with aati-
biotics has led numerous workers to search for antifungal properties of similar
compounds. Among these were two of the authors (Ruth C. Burke and J. H.
Swartz) who in 1950 began to investigate the antifungal properties of a number of
promising agents including various drugs, plants, bacteria and fungi. Although
several antifungal agents were studied, one fungus in particular showed such
promise that work was concentrated on isolating and testing its active principle.
A crystalline material was obtained and tested against a number of representa-
tive bacteria, yeasts, molds and protozoa. This material shows notable activity
in vitro against many of the pathogenic yeasts and molds. At the present time a
complete in vivo evaluation is impossible due to rapid inactivation and moderately
high toxicity of the crystalline material. These two problems are now under con-
sideration and it is hoped that they will be solved in the near future permitting a
more thorough evaluation of the product. We are hopeful that resolving the
problem of rapid inactivation will, at the very least, permit use of the compound
in treatment of the superficial mycoses. In the present paper we would like to
discuss several of the interesting properties exhibited by the antibiotic which has
been named mycotiein.
ORGANI5M
The fungus producing the antibiotic is Strep! omyces ruber. It grows slowly on Sabouraud's
glucose agar to produce a heaped and folded yellow-tinted colony in 2 weeks' time. The
medium surrouoding the colony is considerably darkened in old cultures and is alkaline in
reaction. Streptomyces ruber produces hemolysis in blood agar medium. Fig. 1 shows the
zones of inhibition produced in Sabouraud's glucose agar against several of the pathogenic
fungi including Sporotrichum schenckii and Cryptocoecus neoforrnans, two of the organisms
used for assaying crude and crystalline lots of the antibiotic.
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FIG. 1. Zones of inhibition produced by 2-week old cultures of S. ruber against (a) Crypto-
coccus neoformans, (b) Microsporum audouini, (c) Microsporum gypseum and (d) ,Sporo-
trichum schenckii. Suspensions of the test organisms were prepared in broth and poured onto
the plates. In so doing, a number of the streptomyces spores were carried to other parts of
the plate giving rise to the small colonies evident.
ISOLATION OF MYCOTICIN
S. ruber is grown in shake culture at room temperature in 2.5 liter Fernbach
flasks containing 750 ml of a medium composed of bactopeptone 2%, glucose 2%,
Na2HPO4 0.2%, KC1 0.02%, MgSO4 0.02% and NaC1 0.02%. The medium is
adjusted to pH 6.5—7.0, and is inoculated with 2.5 ml of a suspension of pulver-
ized colonies. Within the 7—10 day incubation period the medium becomes dark
brown and alkaline in reaction and the fungus, which grows as pellets in the me-
dium, bright yellow in color. Upon the production of this yellow pigment, the
mycelium is harvested by ifitering off the culture liquor. As much broth as possi-
ble is removed by pressing the colonies between filter paper. The pigment is then
extracted from the mycelium using warm 95% ethanol. The antibiotic is crystal-
lized from this solution by the addition of water. It can also be extracted with
methanol and crystallized from an acetone-water mixture.
B.
D.
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CHEMICAL AND PHYSICAL PROPERTIES
Mycoticin is a yellow Crystalline substance that fluoresces in ultraviolet. Nitro-
gen, sulfur and the halogens are not present. The antibiotic yields negative tests
for unsaturation using bromine and potassium permanganate tests; it yields
positive tests for ketones using Brady's method (dinitrophenylhydrazine sulfate);
it reduces ammoniacal silver nitrate and Fehling's solution.
Mycoticin is soluble in lower alcohols, propylene and diethylene glycol, sul-
furic and phosphoric acids; it is only partly soluble in water, benzene and acetone
aud is insoluble in ether, petroleum ether, xylene and chloroform. Mycoticin is
dialysable.
The probable formula of mycoticin is C15H3005.
Calculated for CuHasO5 C, 66.23 11, 9.26
Analysis of freshly prepared sample C, 65.90 II, 9.43
Analysis of the sample after standing for 2 weeks C, 63.17 II, 9.03
The ultraviolet spectrum of a freshly prepared sample shows a main band at
363 mcj and two minor bands at 263 and 210 mu (Fig. 2). The main band de-
creases in height with loss of activity; thus the UV spectrum can be used as a
quick method of assay. The 363 mj band can be destroyed by heating with alco-
holic 0.6N sulfuric acid, or aqueous alcoholic 6N hydrochloric acid or aqueous
alcoholic 10% potassium hydroxide, on a steam bath for 2 hours; the 363 mji
band is not affected when heated with aqueous acetic acid or aqueous alcoholic
sodium bicarbonate solution.
Fin. 2. Ultraviolet spectrum of mycoticin in methanol. Concentration .01436 mg/mI.
Courtesy The Lilly Research Laboratories, Eli Lilly and Company.
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The infra red spectrum of a suspension of the antibiotic in mineral oil shows a
strong hydroxyl band at 3.1 j (associated) and medium bands at 5.94, 6.2 and
6.34 z. A pyridine solution shows broad bands at 3.2—3.6 and 5.9—6.4 p.
A tetra-acetyl derivative is formed upon treatment of the antibiotic material
with acetic anhydride and pyridine at room temperature. Melting point of the
acetate is 140—1°C.
Calculated for C26H3809 C, 63.14 II, 7.74
Found C, 63.05, 63.71 H, 7.62, 7.93
The ultraviolet spectrum of the acetate in ethanol shows a maximum band at
361 m and a minor band at 260 m. The infra red spectrum in chloroform shows
a weak band at 3.45 j.; a strong band at 5.75—5.78; sharp medium bands at 6.13
and 6.3 and a broad strong band at 7.95.
Both the antibiotic and its acetate can be readily hydrogenated in ethyl ace-
tate with 10% Pd-on-charcoal catalyst. The hydrogenation products are color-
less, do not fluoresce, show no TJV maximum and have no antifungal activity. A
solution of 30 mg of the crude product, prepared from the acetate, in 1 ml of
chloroform shows no optical activity; the infra red spectrum of the crude product
in chloroform shows a weak hump at 2.9 j, strong bands at 3.45 and 3.52 as well
as a strong band at 5.75—5.83 ji, and a broad strong band at 7.85 x.
Solutions or suspensions of mycoticin prepared in Mcllvaine's buffer show
little or no activity at pH 2 to 5; slight activity at pH 6 to 7and greatest activity
at alkaline pils. Solutions kept at pH 2 for 24 hours are again active when brought
to an alkaline pH. Antifungal activity is not affected by heating at 100°C for 10
minutes at pH 6.
The antibiotic is inactivated very rapidly by exposure to ultraviolet. Since
fluorescence is lost at the same time, ability to fluoresce can be used as a crude
measure of activity. Inactivation also occurs when the crystalline material is
stored in stoppered bottles in the dark at room temperature. Most lots lose their
activity within 2—3 weeks under the latter conditions. Activity can be prolonged,
however, by storage in the dark in vacuo. One lot, stored in this manner for 13
months was found to have a high degree of activity when tested.
The ultraviolet spectrum of a freshly prepared sample shows a main band at
363 m and two minor bands at 263 and 210 m1 (Fig. 2). The main band de-
creases in height with loss of activity; thus, the UV spectrum can be used as a
quick method of assay.
ANTIBIOTIC ACTIVITY
The in vitro antimicrobial activity of mycoticin was determined by agar dilu-
tion and serial dilution methods. In the former method, Sabouraud's glucose agar
and trypsin digest of beef heart agar were used; in the latter, tryptic digest broth.
Yeasts and molds were incubated at room temperature and bacteria at 37°C.
In testing the antimicrobial activity of mycoticin, stock solutions first were
prepared by dissolving 10 mg in 95% ethanol. Subsequent dilutions were made
in distilled water or broth. As a general practice stock solutions were kept no
longer than 24 hours to insure an active material at all times. Concentrations of
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FIG. 3. Activity of mycoticin against various microorganisms
ORGANISM INHIBITORY CONCENTRATIONMCG/ML, 96 HOURS ON AGAR
Cry plococcus neoformans ATCC 10226 6—8
Candida albicans ATCC 10261 6—10
Blastomyces dermatitidis ATCC 10225 2—4
Histoplasma capsulatum ATCC 10229 1—2
Sporotrichum schenckii ATCC 10213 1—3
Hormodendrum pedrosoi ATCC 9475 7—10
Coccidioides immitis Conant 2150 2—3
Trichophyton mentagrophytes ATCC 9972 5—7
T. men.tagrophytes Harvard 16 6—9
T. rubrum
Microsporum audouini
ATCC 9806
ATCC 10216
35
2—3
M. canis ATCC 9084 4—7
M. gypseum Harvard 22 8—10
Bacillus subtilis >100
Escherichia coli >100
Staphylococcus aureus >100
Mycobacterium phlei >100
Streptococcus hemolyticus >100
Salmonella typhi >100
Leishmania donovani >100
Tryphanosoma tropica >100
Endamoeba histolytica >100
0.5 to 10, 25, 50 and 100 meg/mi were prepared in Sabouraud's or tryptic digest
agar and the medium inoculated with 0.05 ml of a 24-hour broth culture of bacte-
ria and yeasts and with 0.1 ml of a spore or mycelial suspension of molds. A
3-week old culture of Mycobacterium phlei was used. Plates were examined at the
end of 24, 48, 72 and 96 hours; final readings were made at the end of 9 days.
Mycoticin was found to be active only against yeasts and molds; it did not
inhibit several species of bacteria and protozoa at the concentrations used. In
general, mycoticin was most effective against the systemic pathogens, Histo-
plasma capsulatum, Coccidioides immitis, Blastom yeas dermatitidis and Spore-
trichum schenckii. Better results were obtained in agar than in broth: only 1 to 4
mcg/ml were required in agar to inhibit completely the growth of these 4 patho-
gens. There was very little difference in the inhibitory concentrations for the
yeast and mycelial phases of H. capsulatum, B. dermatitidis and S. schenckii.
There is some evidence that those dermatophytes which produce large numbers of
conidia are less inhibited than those forming only a few conidia. For example,
Microsporuns audouini was completely inhibited by 2—3 meg/mi whereas M.
gypseum required 3 times that concentration. Similarly, of the 2 strains of Tn-
chophyton meniagrophytes tested, the one which produced large numbers of coni-
dia consistently required 2—3 meg/mi more for complete inhibition. Fig. 3 indi-
cates activity of mycoticin against various microorganisms.
Sensitivity of S. schenckii to mycoticin was determined in tryptic digest broth
culture. Using the stock solution of mycoticin, serial dilutions were prepared in
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4.5 ml of broth and heated to 700 C for 10 minutes to insure sterility. The tubes
were allowed to cool and then inoculated with 0.5 ml of a saline suspension of
the yeast phase so that the final concentration in the test tubes was 50,000
cells ml. The cultures were incubated at 37°C and examined for growth at the
end of 24, 48, 72 and 96 hours. Sensitivity was recorded as the smallest amount
of antibiotic required to inhibit growth as evidenced by the absence of turbidity
at the end of 96 hours. Under the above conditions, sensitivity between 2—4
mcg/ml was noted for S. schenclcii.
Some of the pharmacological data obtained up to the present time indicate
that an approximate LD 50 of mycoticin in saline suspension or emulsion admin-
istered intraperitoneally is between 10—20 mg/kg body weight in mice. Autopsied
animals showed no evidence of the hemolysis evident in in vitro studies. The
peritoneum showed considerable irritation and some accumulation of body fluids.
The LD 50 for subcutaneous administration is considerably higher but has not
yet been determined because the insoluble compound remains at the site of inj cc-
tion and results after a few days in skin necrosis and sloughing. One hundred mg
dissolved in propylene glycol and injected subcutaneously produced no immedi-
ately observable ill effects; however, sloughing of the skin at site of injection was
noted after several days.
Preliminary patch tests to determine cutaneous hypersensitivity to mycoticin
were performed with the antibiotic incorporated in propylene glycol or carbowax.
Concentrations up to 1 mg/ml or gm of the vehicle were used. Control tests for
hypersensitivity to the vehicles were also done. The test sites were the flexor sur-
faces of the forearms. The patches were removed in 48 hours and read. They were
also read every day for 5 days thereafter. No reactions were noted in the 30 per-
sons tested. In one instance, an area of erythema the size of a nickle was detected
at the test site; a similar reaction to the control (propylene glycol) was present in
the same person. A larger series of patch tests is necessary to evaluate the degree
of hypersensitivity to mycoticin. This will be reported in a future communication.
SUMMARY
1. A new antifungal antibiotic has been isolated in crystalline form from Strepto-
myces ruber.
2. The antibiotic, mycoticin is particularly active in vitro against C. immitis,
H. capsulatum, B. dermatitidis, S. schenclcii and M. audouini.
3. The antibiotic, which has a probable chemical formula of C18H3505, has
several interesting features including ability to fluoresce under ultraviolet, a
property that can be roughly correlated with activity.
4. The crystalline material rather rapidly becomes inactivated unless stored in
vacuo. A fairly accurate estimation of antifungal activity can be determined by
ultraviolet spectrum.
5. Toxicity is quite high: the approximate LD 50 being between 10—20 mg/kg
body weight when administered intraperitoneally to mice. Hemolysis was not
evident in the autopsied animals.
